Since patients with PCOS typically have high LH and low FSH levels, estrogen receptor antagonists or aromatase inhibitors are used to reduce the negative feedback of estrogen on pituitary FSH secretion, or exogenous FSH is used to assist ovulation [25]. Here, CYP19A1 is linked to polycystic ovary syndrome.